Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 25-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 10)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49  View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - REXAHN PHARMACEUTICALS INC. (RNN-A)11$25  View Abstract
21-Apr-14GlobalDataGlobalDataRexahn Pharmaceuticals, Inc. (RNN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile30$250  View Abstract
19-Apr-14Pechala's ReportsFrantisek PechalaREXAHN PHARMACEUTICALS INC (RNN) 12-months forecast1$15  View Abstract
19-Apr-14Reuters Investment ProfileN/ARexahn Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
17-Apr-14Ford Investor Services, Inc.N/AValue Graph: REXAHN PHARMA -- RNN1$11.50  View Abstract
17-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: CRXM , OHRP , RNN , THLD -- DRUGS3$34.50  View Abstract
15-Apr-14Zacks Investment Research Inc.N/AREXAHN PHARMACT (RNN) Zacks Company Snapshot1$11.50  View Abstract
2-Apr-14Zacks Investment Research Inc.N/AREXAHN PHARMACT (RNN) Zacks Company Snapshot1$11.50  View Abstract
19-Mar-14GlobalDataGlobalDataRexahn Pharmaceuticals, Inc. (RNN) - Financial Analysis Review33$125  View Abstract

Independent Reports (Showing 1 to 10 of 10)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49View Abstract
23-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - REXAHN PHARMACEUTICALS INC. (RNN-A)11$25View Abstract
21-Apr-14GlobalDataGlobalDataRexahn Pharmaceuticals, Inc. (RNN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile30$250View Abstract
19-Apr-14Pechala's ReportsFrantisek PechalaREXAHN PHARMACEUTICALS INC (RNN) 12-months forecast1$15View Abstract
19-Apr-14Reuters Investment ProfileN/ARexahn Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
17-Apr-14Ford Investor Services, Inc.N/AValue Graph: REXAHN PHARMA -- RNN1$11.50View Abstract
17-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: CRXM , OHRP , RNN , THLD -- DRUGS3$34.50View Abstract
15-Apr-14Zacks Investment Research Inc.N/AREXAHN PHARMACT (RNN) Zacks Company Snapshot1$11.50View Abstract
2-Apr-14Zacks Investment Research Inc.N/AREXAHN PHARMACT (RNN) Zacks Company Snapshot1$11.50View Abstract
19-Mar-14GlobalDataGlobalDataRexahn Pharmaceuticals, Inc. (RNN) - Financial Analysis Review33$125View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.